Tsfg LLC Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Tsfg LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 389 shares of the healthcare conglomerate’s stock after selling 60 shares during the quarter. Tsfg LLC’s holdings in UnitedHealth Group were worth $197,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. State Street Corp boosted its stake in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares during the last quarter. Geode Capital Management LLC grew its stake in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. boosted its holdings in shares of UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. International Assets Investment Management LLC raised its position in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after purchasing an additional 880,183 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 4.0 %

Shares of NYSE UNH opened at $541.28 on Tuesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $498.13 billion, a P/E ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. The firm’s 50 day simple moving average is $554.92 and its two-hundred day simple moving average is $562.88. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the business posted $6.56 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday. Two analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $626.79.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.